Clinical Trials Logo

Filter by:
NCT ID: NCT02258178 Withdrawn - Clinical trials for Pregnant Women, Influenza

Flucelvax Pregnancy Registry

Start date: September 2014
Phase: N/A
Study type: Observational

The goal of the registry is to develop a better understanding of the safety of Flucelvax in women and their offspring who were exposed to the vaccine during pregnancy

NCT ID: NCT02258048 Withdrawn - Cirrhosis Clinical Trials

The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early Cirrhosis

Start date: October 2014
Phase: N/A
Study type: Observational

This is a prospective study designed to examine the role of transient elastography as a predictor of clinical decompensation in patients with early cirrhosis. The study objective is to determine if changes in measurements of liver stiffness with transient elastography can identify patients that will have a more rapid progression of cirrhosis and the development of clinical decompensation. The target population is patients with early stage, well-compensated cirrhosis. Participants of this study will be asked to complete the following procedures: read and sign the informed consent, medical records review (complete medical history, physical examination, laboratory evaluation, endoscopic findings, radiographic findings), undergo transient elastography to measure liver stiffness every three months until the development of clinical decompensation (ascites, variceal bleeding, hepatorenal syndrome, overt hepatic encephalopathy) for up to 2 years.

NCT ID: NCT02257879 Withdrawn - Healthy Volunteers Clinical Trials

DHB Supplement Interaction Study

Start date: October 3, 2014
Phase:
Study type: Observational

Background: - Drinking grapefruit juice changes how long it takes some medicines to be broken down in the body. Researchers have found that a substance in grapefruit juice called DHB contributes to this effect. Some dietary supplements contain DHB and claim to increase the absorption of any and all supplements, medicine or any other drug. But these usually contain a lot more DHB than a glass of grapefruit juice. Researchers want to study the effects of grapefruit juice and supplements with DHB. Objective: - To compare how a certain dietary supplement (sold as DHB-300 ) versus grapefruit juice affects how long it takes a person s body to break down medicines. Eligibility: - Healthy volunteers ages 18 - 60. Design: - Participants will be screened with medical history, physical exam, and blood and urine tests. - Participants will have 3 treatment visits. Participants cannot drive themselves home from the visits. Each visit lasts about 13.5 hours and includes: - Questions about medications and participant s health. - Vital signs taken. - A finger probe to measure oxygen. - Blood and urine sampling throughout the visit. - An IV line inserted into an arm vein. It will stay there throughout the visit. - Study treatments: - Midazolam hydrochloride a syrup given to make people sleepy. - Loperamide a tablet for treating diarrhea. - 1 glass of water, 1 glass of grapefruit juice, or 1 pill of DHB-300. A different one will be given at each treatment visit. - One week before each visit, participants cannot have certain fruits and juices. They must fast the night before each visit. - For the 3 days after each visit, participants will return to the clinic 4 times. Their vital signs will be checked and blood will be drawn.

NCT ID: NCT02257788 Withdrawn - HIV Clinical Trials

PRO 140 for Human Immunodeficiency Virus Infection

Start date: September 2014
Phase: Phase 2
Study type: Interventional

PRO 140 2103 is a multicenter, randomized parallel group study, conducted in male and female adult subjects infected with CCR5-tropic HIV-1.

NCT ID: NCT02257346 Withdrawn - Pregnancy Clinical Trials

Intravenous Lidocaine and Quality of Recovery After Cesarean Delivery

Start date: November 1, 2014
Phase: N/A
Study type: Interventional

When given intravenously, the local anesthetic lidocaine has been shown to decrease the amount of pain medication patients require when recovering from several types of surgeries. Cesarean delivery is a very common surgery in the United States, effecting more than 1 million women each year. The investigators hypothesize that lidocaine, given during and immediately after a patient undergoes a cesarean section, will help improve a mother's overall recovery experience, as well as positively influence bonding with her new baby.

NCT ID: NCT02255877 Withdrawn - Clinical trials for Arthroplasty, Replacement, Knee

ZIPS Study - Zip Incision Approximation vs. STAPLE

ZIPS
Start date: September 2014
Phase: Phase 4
Study type: Interventional

Study designed to evaluate the Zip Surgical Skin Closure device versus conventional steel staple placement when utilized for surgical wound closure after bi lateral unicompartmental or bi later total knee replacement.

NCT ID: NCT02255825 Withdrawn - Major Fetal Anomaly Clinical Trials

Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis

Start date: October 2014
Phase: N/A
Study type: Interventional

To gain knowledge about how patients undergoing prenatal diagnosis for a fetal abnormality understand and react to Whole Genome Sequencing (WGS) testing, so that the investigators can develop more ethical and responsible approach to patient education, counseling, and return of results for patients.

NCT ID: NCT02255240 Withdrawn - Breast Cancer Clinical Trials

LEVEL UP: Video Games for Activity in Breast Cancer Survivors

LEVEL UP
Start date: September 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test an intervention that uses home console video games to encourage increased physical activity among postmenopausal breast cancer survivors.

NCT ID: NCT02252978 Withdrawn - Prostate Cancer Clinical Trials

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Start date: July 2016
Phase: Phase 2
Study type: Interventional

This phase II trial studies ciprofloxacin compared to an inactive treatment (placebo) in diagnosing prostate cancer in patients undergoing removal of prostate cells or tissues for examination (biopsy). Ciprofloxacin is an antibiotic, a type of drug used to treat infections caused by bacteria. Giving ciprofloxacin to patients undergoing a prostate biopsy may help to lower abnormal prostate-specific antigen (PSA) levels caused by bacterial infection of the prostate gland and may or may not affect the detection rate of prostate cancer.

NCT ID: NCT02250924 Withdrawn - Clinical trials for C.Surgical Procedure; Digestive System

Caffeinated Gum to Prevent Post-Operative Ileus: A Prospective, Randomized, Placebo-controlled Trial

Start date: January 2017
Phase: N/A
Study type: Interventional

This is a randomized, three-arm, double-blind, placebo-controlled, Phase III clinical trial of caffeinated gum and sugar-less gum in adult patients after an abdominal procedure. Patients will be randomized to receive placebo, sugar-less gum or caffeinated gum three times daily for 30 minutes starting the day following surgery until discharge or 24 hours after attainment of the primary endpoint.